• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

COVID-19: MEDITECH Offers Expanse Ambulatory Expanse Customers It’s Scheduled Virtual Visits Functionality Free of Charge

by Fred Pennic 03/18/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
COVID-19: MEDITECH Offers Expanse Ambulatory Expanse Customers Its Scheduled Virtual Visits Functionality Free of Charge

What You Should Know:

MEDITECH offers Expanse Ambulatory and Patient Portal users complimentary deployment of our Scheduled Virtual Visits functionality for a six-month period.

This solution, deployed through MEDITECH’s rapid response team, can assist customers in battling the spread of the COVID-19, reducing unnecessary risk to others and identifying the patients in need of care.


In an effort to help combat the COVID-19 pandemic, MEDITECH announced it will offer all customers installed with the Expanse Ambulatory and Patient Portal solutions a complimentary deployment of its Scheduled Virtual Visits software capabilities, free of charge for a six-month period. This Scheduled Virtual Visits solution assist customers in battling the spread of the virus during this extraordinarily challenging time, reducing unnecessary risk to others and identifying the patients in need of care.

How Virtual Visits Help Limit Spread of COVID-19

As healthcare organizations grapple with the new realities of the pandemic, many are turning to virtual visits as providers brace for an influx of patients with suspected cases. Leveraging virtual visits is one method to help reduce the volume of patients arriving unexpectedly in the ED or physician’s office where they risk infecting other patients and staff. Instead, providers can practice social distancing by screening and treating patients remotely and directing them to the safest and most appropriate testing location, including the increase in drive-up testing.

The unprecedented nature of the COVID-19 pandemic has the potential to put a strain on healthcare and healthcare resources, and we must all do our part to assist in any way possible to manage this crisis. In partnership with customers, the company will continue to offer guidance on how to use the MEDITECH EHR to address demands as quickly as possible, using remote technologies like virtual visits.

In addition, MEDITECH is working closely with all customers and customer-led forums in a variety of ways to ensure they can leverage the power and potential of the EHR to manage through this crisis. We will continue to take proactive measures to assist customers in their efforts around data capture, clinical decision support, the utilization of surveillance, status boards and clinical analytic tools.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Decision Support, Coronavirus (COVID-19), decision support, MEDITECH, Patient Portal, Portal, risk, Virtual Visits

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |